Phenylisothiocyanate and dansyl chloride precolumn derivatizations for the high-performance liquid chromatography analysis of the antitumoral agent ES-285 in dog plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 791, Issue 1-2, 2003, Pages 1-11

  Maraschiello, C ^a   Miranda, E ^b   Millan E ^b   Floriano, P ^b   Vilageliu, J ^a  

^a DEPT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^b PHARMAMAR S A   (Spain)

Author keywords

Dansyl chloride; Derivatization, LC; ES 285; Phenylisothiocyanate

Indexed keywords

AMINES; BODY FLUIDS; CHLORINE COMPOUNDS; CHROMOPHORES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TUMORS;

ANTITUMORAL AGENTS;

AROMATIC COMPOUNDS;

2 AMINO 3 HYDROXYOCTADECANE; ANTINEOPLASTIC AGENT; DANSYL CHLORIDE; ES 285; ES 299; PHENYL ISOTHIOCYANATE; TRIETHYLAMINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DOG; DRUG DETERMINATION; DRUG ISOLATION; DRUG PURIFICATION; ELUTION; FLOW RATE; FLUORESCENCE; HEAT TREATMENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; STANDARD; TEMPERATURE; ULTRAVIOLET IRRADIATION; VALIDATION PROCESS;

CANIS FAMILIARIS;

EID: 0038359617     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(03)00161-2     Document Type: Article

References (23)

1. Jimeno J.M., Garcia-Gravalos D., Avila J., Smith B., Grant W., Faircloth G.T. Proc. Am. Assoc. Cancer Res. 5S:1999;3792s.
2. Cuadros R., Montejo de Garcini E., Wandosell F., Faircloth G., Fernández-Sousa J.M., Avila J. Cancer Lett. 152:2000;23.
3. Mackay D.J., Hall A. J. Biol. Chem. 273:1998;20685.
4. Cuvillier O., Pirianov G., Kleuser B., Vanek P.G., Coso O.A., Gutkind J.S., Spiegel S. Nature. 381:1996;800.
5. Cohen K.A., Dolan J.W., Grillo S.A. J. Chromatogr. A. 316:1984;359.
6. Cohen S.A., Bidlingmeyer B.A., Tarvin T.L. Nature. 320:1986;769.
7. Hagen S.R., Augustin J., Grings E., Tassinari P. Food Chem. 46:1993;319.
8. De Jong C., Hughes G.J., Van Wieringen E., Wilson K.J. J. Chromatogr. A. 241:1982;345.
9. Weinstein S., Weiner S. J. Chromatogr. A. 303:1984;244.
10. Simmaco M., De Biase D., Barra D., Bossa F. J. Chromatogr. A. 504:1990;129.
11. International Conference on Harmonisation (ICH) (1996) Topic Q2A: Validation of Analytical Procedures: Definitions and Terminology.
12. International Conference on Harmonisation (ICH) (1996) Topic Q2B: Validation of Analytical Procedures: Methodology.
13. Shah P.V., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., Yacobi A. Pharm. Res. 17:2000;1551.
14. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM): Guidance for Industry: Bioanalytical Method Validation, May 2001.
15. EURACHEM Working Group, The Fitness for Purpose of Analytical Methods: A Laboratory Guide to Method Validation and Related Topics, 1998.
16. Edman P. Acta Chem. Scand. 4:1950;277.
17. Edman P., Begg G. Eur. J. Biochem. 1:1967;80.
18. Heinrikson R.L., Meredith S.C. Anal. Biochem. 136:1984;65.
19. Beaver R.W., Wilson D.M., Jones H.M., Haydon K.D. J. Assoc. Off. Anal. Chem. 70:(3):1987;425.
20. Ohkura Y., Kai M., Nohta H. J. Chromatogr. B. 659:1994;85.
21. Cohen J.L., Ko R.J., Lo A.T.L., Shields M.D., Gilman T.M. J. Pharm. Sci. 78:(2):1989;115.
22. Guitart A., Hernández P., Cacho J. Analyst. 116:1991;399.
23. Hagen S.R., Frost B., Augustin J. J. Assoc. Off. Anal. Chem. 72:(6):1989;912.